About Meril
Meril is a company based in Vapi (India) founded in 2006 by Shahid Bilakhia. Meril has raised $410 million across 2 funding rounds from investors including Warburg Pincus and Abu Dhabi Investment Authority. The company has 1,584 employees as of February 10, 2025. Meril offers products and services including BioMimeTM, MirusTM, and OPULENT BIONIK GOLD KNEE. Meril operates in a competitive market with competitors including GE Healthcare, Medtronic, Boston Scientific, Baxter and CONMED, among others.
- Headquarter Vapi, India
- Employees 1584 as on 10 Feb, 2025
- Founders Shahid Bilakhia
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Meril Life Sciences Pvt. Ltd.
- Jurisdiction Vapi, Gujarat, India
-
Annual Revenue
$140.5 M (USD)47.5as on Mar 31, 2024
-
Net Profit
$21.16 M (USD)-14.09as on Mar 31, 2024
-
EBITDA
$36.38 M (USD)-1.95as on Mar 31, 2024
-
Total Equity Funding
$410 M (USD)
in 2 rounds
-
Latest Funding Round
$200 M (USD), Series D
Jul 21, 2025
-
Investors
Warburg Pincus
& 1 more
-
Employee Count
1584
as on Feb 10, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Meril
Meril offers a comprehensive portfolio of products and services, including BioMimeTM, MirusTM, and OPULENT BIONIK GOLD KNEE.
Sirolimus Eluting Coronary Stent System for vascular treatment
Linear cutter for surgical procedures with varied tissue options
Knee replacement implant with durable, biocompatible coating
Funding Insights of Meril
Meril has successfully raised a total of $410M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $200 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series D — $200.0M
-
First Round
First Round
(22 Feb 2022)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Series D - Meril | Valuation |
investors |
|
| Feb, 2022 | Amount | Private Equity Round - Meril | Valuation |
investors |
Investors in Meril
Meril has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Warburg Pincus and Abu Dhabi Investment Authority.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Founded Year | Domain | Location | |
|
Long-term value is created through diversified sovereign wealth investments.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Meril
Financial Statements - Meril
Meril Comparisons
Competitors of Meril
Meril operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GE Healthcare, Medtronic, Boston Scientific, Baxter and CONMED, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Materials management solutions are provided for healthcare organizations.
|
|
| domain | founded_year | HQ Location |
Medical equipment for treating over 30 chronic diseases is developed.
|
|
| domain | founded_year | HQ Location |
Wide range of medical devices
|
|
| domain | founded_year | HQ Location |
Biosciences, medication delivery, and renal products are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Surgical instruments are manufactured for multiple therapeutic areas.
|
|
| domain | founded_year | HQ Location |
Healthcare solutions are provided by Johnson & Johnson globally.
|
Frequently Asked Questions about Meril
Meril was founded in 2006 and raised its 1st funding round 16 years after it was founded.
Meril is headquartered in Vapi, India. It is registered at Vapi, Gujarat, India.
Vivek Shah is the current CEO of Meril.
Meril is a funded company, having raised a total of $410M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $210M, raised on Feb 22, 2022.
As of Feb 10, 2025, the latest employee count at Meril is 1,584.
Annual revenue of Meril is $140.5M as on Mar 31, 2024.
Developer of medical devices for surgeries and diagnosis. The company manufactures medical solutions in the form of vascular intervention devices, orthopedic implants, robotics, endo-surgery, ENT products, and in-vitro diagnostics.
Meril's top competitors include GE Healthcare, Medtronic and Boston Scientific.
Meril offers BioMimeTM, MirusTM, and OPULENT BIONIK GOLD KNEE.
Meril has 2 investors. Key investors include Warburg Pincus, and Abu Dhabi Investment Authority.